Pear VC — 2014 Investments
3 investments dated 2014 · listed companies and verified rows first · show all
Guardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease.
BiotechDigital HealthHealthtechMedical DevicesRedwood City, US
AmirAli Talasaz(Executive Officer, Director)inHelmy Eltoukhy(Executive Officer, Director)inMichael Wiley(Executive Officer)inMichael Bell(Chief Financial Officer)Darya Chudova(Chief Technology Officer)inCraig Eagle(Chief Medical Officer)in
Co-investors8VCAUTHENTIC VENTURESCota CapitalFelicis VenturesKhosla VenturesKnockout Capital+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EvergiveFieldbook
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.